+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Retinyl Palmitate Market - Market Size & Forecasting (2017-2028)

  • PDF Icon

    Report

  • 110 Pages
  • May 2021
  • Region: Global
  • Quince Market Insights
  • ID: 5450155
UP TO OFF until Jul 31st 2023
The global retinyl palmitate market was estimated at USD 866.7 million in 2020 and is projected to register a CAGR of 4.6%, reaching USD 1,239.8 million by 2028. However, due to the COVID-19 impact, the estimated market size in 2020 has come down to USD 859.6 million and is projected to register a CAGR of 3.7% to reach USD 1,152.3 million by 2028.



This research report categorizes the market for retinyl palmitate based on various segments and region and forecasts revenue growth and analysis of trends in each of the sub markets. The report analyses the key growth drivers, opportunities and challenges which influence the Retinyl Palmitate market. Recent market developments and competitive strategies such as expansion, product launch and development, partnership, merger and acquisition have been included in order to draw the competitive landscape in the Retinyl palmitate market. The report strategically identifies and profiles the key market players and analyses their core competencies in each segment such as type, product and application of the Retinyl palmitate market.

Based on type, the retinyl palmitate market is segmented into industrial grade and food grade. The industrial grade type will capture major market shares in the global retinyl palmitate market over the forecast period. The demand for industrial grade retinyl palmitate is mainly driven by factors such as increased awareness about skin care, which raises the demand for retinyl palmitate in the cosmetic industry.

Based on product type, the retinyl palmitate market is segmented into natural and synthetic. The natural product type segment will have major shares in the global retinyl palmitate market during the forecast period. The natural product type contains major sources of vitamin A, such as raw vegetables like carrots, spinach, tomatoes, lemongrass, and sweet potatoes, and palm oil (CPO), which serve as the raw materials from which vitamin A is extracted. Animal raw materials include beef liver, chicken eggs, cow's milk, salmon, chicken, and meat.

Based on application, the retinyl palmitate market is segmented into animal feed additives, human nutrition, cosmetics, and others. The human nutrition application segment will contribute key market share in the global retinyl palmitate market over the forecast period. Vitamin A deficiency causes growth retardation, night blindness, and makes the organism more vulnerable to infections, while vitamin A supplementation has been shown to improve immune response. This is expected to promote the growth of the human nutrition segment over the forecast period.

Region-wise, the retinyl palmitate market has been segmented as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The North America region will hold the largest market share in the global retinyl palmitate market during the forecast period. The retinyl palmitate market is expected to develop rapidly over the forecast period in the North America region. Consumer spending on cosmetics and skincare products is expected to drive the regional market development. The medical and pharmaceutical industries should drive market growth due to their broad application reach. FDA-friendly regulations can also provide a major stimulus to industry growth.

WHAT THIS STUDY PROVIDES

  • Global market and sub market forecast covering the period of 2017 to 2028, with accompanying analysis
  • Retinyl palmitate market and sub market forecast covering the period of 2017 to 2028, with accompanying analysis
  • Extensive details and analysis of contracts, projects, and programs
  • Analysis of game-changing technological trends and how these will shape the industry
  • Explanation or political, regulatory and technical factors to consider
  • Barriers to entry analysis for markets around the world
  • Profiles of leading companies operating within the sector with market share analysis
  • SWOT analysis of the major strengths and weaknesses of the market, together with the opportunities available and the key threats faced
  • Market conclusions & recommendations

KEY QUESTIONS ANSWERED BY THIS REPORT

  • How the retinyl palmitate market is evolving?
  • What is driving and restraining factors for global retinyl palmitate Market?
  • How will each retinyl palmitate sub-market segment grow over the forecast period and how much sales will these sub-markets account for in 2028?
  • How will market shares of each retinyl palmitate sub-market develops from 2017-2028?
  • Which retinyl palmitate sub-market will be the main driver of the overall market from 2017-2028?
  • How will political and regulatory factors influence regional retinyl palmitate markets and sub-markets?
  • Will leading national retinyl palmitate broadly follow macroeconomic dynamics, or will individual country sectors outperform the rest of the economy?
  • How will market shares of the national markets change by 2028 and which nation will lead the market in 2028?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the sector evolve as alliances form during the period between 2017 and 2028?
Frequently Asked Questions about the Retinyl Palmitate Market

What is the estimated value of the Retinyl Palmitate Market?

The Retinyl Palmitate Market was estimated to be valued at $794.7 Million in 2017.

What is the growth rate of the Retinyl Palmitate Market?

The growth rate of the Retinyl Palmitate Market is 3.4%, with an estimated value of $1152.3 Million by 2028.

What is the forecasted size of the Retinyl Palmitate Market?

The Retinyl Palmitate Market is estimated to be worth $1152.3 Million by 2028.

Who are the key companies in the Retinyl Palmitate Market?

Key companies in the Retinyl Palmitate Market include Royal Dsm, Archer Daniels Midland (Adm), Piramal Pharma Solutions, Basf Se, Divi’S Laboratories Limited, Bluestar Adisseo, Pfizer Inc. Bayer Ag, Rochem International Inc., Hangzhou Think Chemical Co. Ltd (Thinkchem) and Xiamen Kingdomway Group Company.

Table of Contents

1 Market Abstract
2 Market Introduction
2.1 Market Scope
2.2 Key Definitions-Content
2.2.1 Retinyl Palmitate/Vitamin a Palmitate/Retinol Palmitate:
2.2.2 Synthetic Nutrients:
2.2.3 Fortified or Enriched Foods Products:
2.2.4 Animal Feed Additives:
3 Research Practice
3.1 Research Practice
3.1.1 Supply Based Analysis
3.1.2 Demand Based Analysis
3.1.3 Global Level Analysis
3.1.4 Country Level Analysis
3.1.5 Triangulation
3.2 Primary Data
3.3 Secondary Data
3.4 Market Evaluation & Forecasting Methodology
3.5 Assumptions/ Limitations for the Study
3.6 What this Study Provides
3.7 Key Questions Answered by this Report
3.8 this Study is Intended for
4 Key Related Data
4.1 Competitive Positioning
4.1.1 Product Positioning
4.1.2 Regional Reach Positioning
4.2 Major Investments in the Last Five Years by Global Players
4.3 Key Industry Trends in Major Countries
4.3.1 Increase in Demand for Fortified Foods and Beverages
4.3.2 Substantial Growth of Global Health and Wellness Industry
4.3.3 Increasing Demand for Anti-Aging and Anti-Pollution Ranges
4.4 Technological Advancement
4.5 Guidelines / Regulations
4.5.1 the Food Safety and Standards (Fortification of Foods) Regulations, 2018
4.5.1.1 Standards on Fortification
4.5.1.2 Compliance With Micro-Nutrient Content Requirements in Fortified Food
4.5.2 U.S. Food & Drug Archer Daniels Midland (Adm)Inistration
4.5.3 Regulations Applicable to Health Claims
4.6 Covid- 19 Impact on Retinyl Palmitate Market
5 Impact Factor Analysis
5.1 Drivers/Restraints/Opportunities/Challenges
5.1.1 Drivers
5.1.2 Restraints
5.1.3 Opportunity
5.1.4 Challenges
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Buyers: (Moderate)
5.2.2 Bargaining Power of Suppliers: (Moderate)
5.2.3 Intensity of Rivalry: (Moderate)
5.2.4 Threat of New Entrants: (Moderate)
5.2.5 Threat of Substitutes: (High)
6 Market Development Analysis
6.1 Overview
6.2 New Product Development (2015-2021)
6.3 Merger & Acquisitions (2015-2021)
6.4 Partnership/Agreements/Collaborations (2015-2021)
7 Global Retinyl Palmitate Market, by Type
7.1 Introduction
7.2 Industrial Grade
7.3 Food Grade
8 Retinyl Palmitate Market, by Product Type
8.1 Introduction
8.2 Natural
8.3 Synthetic
9 Global Retinyl Palmitate Market, by Application
9.1 Introduction
9.2 Human Nutrition
9.3 Cosmetics
9.4 Animal Feed Additives
9.5 Others
10 Retinyl Palmitate Market, Regional Analysis
10.1 Introduction
10.2 North America
10.3 Asia-Pacific
10.4 Europe
10.5 Middle East & Africa
10.6 South America
11 Company Profile
11.1 Royal Dsm
11.1.1 Company Overview
11.1.2 Royal Dsm: Financial Overview
11.1.3 Royal Dsm: Product Overview
11.1.4 Royal Dsm: SWOT Analysis
11.1.5 Royal Dsm: Key Developments
11.2 Archer Daniels Midland (Adm)
11.2.1 Company Overview
11.2.2 Archer Daniels Midland (Adm): Financial Overview
11.2.3 Archer Daniels Midland (Adm): Product Overview
11.2.4 Archer Daniels Midland (Adm): SWOT Analysis
11.2.5 Archer Daniels Midland Company (Adm): Key Developments
11.3 Piramal Pharma Solutions
11.3.1 Company Overview
11.3.2 Piramal Pharma Solutions: Financial Overview
11.3.3 Piramal Pharma Solutions: Product Overview
11.3.4 Piramal Pharma Solutions: SWOT Analysis
11.4 Basf Se
11.4.1 Company Overview
11.4.2 Basf Se: Financial Overview
11.4.3 Basf Se: Product Overview
11.4.4 Basf Se: SWOT Analysis
11.4.5 Basf Se: Key Developments
11.5 Divi's Laboratories Limited
11.5.1 Company Overview
11.5.2 Divi's Laboratories Limited: Financial Overview
11.5.3 Divi's Laboratories Limited: Product Overview
11.5.4 Divi's Laboratories Limited: SWOT Analysis
11.6 Bluestar Adisseo
11.6.1 Company Overview
11.6.2 Bluestar Adisseo: Parent Company Financial Overview
11.6.3 Bluestar Adisseo: Product Overview
11.6.4 Bluestar Adisseo: SWOT Analysis
11.6.5 Bluestar Adisseo: Key Developments (2015-2020)
11.7 Pfizer Inc.
11.7.1 Company Overview
11.7.2 Pfizer Inc.: Financial Overview
11.7.3 Pfizer Inc.: Product Overview
11.7.4 Pfizer Inc.: SWOT Analysis
11.7.5 Pfizer Inc: Key Developments (2015-2021)
11.8 Bayer AG
11.8.1 Company Overview
11.8.2 Bayer Ag: Parent Company Financial Overview
11.8.3 Bayer Ag: Product Overview
11.8.4 Bayer Ag: SWOT Analysis
11.8.5 Bayer Ag: Key Developments (2015-2020)
11.9 Rochem International Inc.
11.9.1 Company Overview
11.9.2 Rochem International Inc.: Product Overview
11.9.3 Rochem International Inc.: Key Developments (2015-2020)
11.10 Hangzhou Think Chemical Co.Ltd (Thinkchem)
11.10.1 Company Overview
11.10.2 Hangzhou Think Chemical Co. Ltd (Thinkchem): Product Overview
11.11 Xiamen Kingdomway Group Company
11.11.1 Company Overview
11.11.2 Xiamen Kingdomway Group Company: Product Overview
11.12 Kangcare Bioindustry Co, Ltd
11.12.1 Company Overview
11.12.2 Kangcare Bioindustry Co, Ltd: Product Overview
11.13 Pharmavite
11.13.1 Company Overview
11.13.2 Pharmavite: Product Overview
11.14 Crystal Pharma
11.14.1 Company Overview
11.14.2 Crystal Pharma: Product Overview
12 Appendix
12.1 List of Abbreviation
12.2 Key Related Reports
List of Tables
Table 1 Drivers
Table 2 Restraints
Table 3 Opportunity
Table 4 Challenges
Table 5 New Product Development (2015-2021)
Table 6 Merger & Acquisitions (2015-2021)
Table 7 Partnership/Agreements/Collaborations (2015-2021)
Table 8 Global Retinyl Palmitate Market, by Type - Under Covid-19 (Usd Million) 2017-2028
Table 9 Global Retinyl Palmitate Market, by Type - (Usd Million) 2017-2028
Table 10 Industrial Grade Market, by Region -Under Covid-19 (Usd Million) 2017-2028
Table 11 Industrial Grade Market, by Region (Usd Million) 2017-2028
Table 12 Food Grade Market, by Region -Under Covid-19 (Usd Million) 2017-2028
Table 13 Food Grade Market, by Region (Usd Million) 2017-2028
Table 14 Global Retinyl Palmitate Market, by Product Type- Under Covid-19 (Usd Million) 2017-2028
Table 15 Global Retinyl Palmitate Market, by Product Type- (Usd Million) 2017-2028
Table 16 Natural Market, by Region -Under Covid-19 (Usd Million) 2017-2028
Table 17 Natural Market, by Region (Usd Million) 2017-2028
Table 18 Synthetic Market, by Region -Under Covid-19 (Usd Million) 2017-2028
Table 19 Synthetic Market, by Region (Usd Million) 2017-2028
Table 20 Global Retinyl Palmitate Market, by Application - Under Covid-19 (Usd Million) 2017-2028
Table 21 Global Retinyl Palmitate Market, by Application - (Usd Million) 2017-2028
Table 22 Human Nutrition Market, by Region -Under Covid-19 (Usd Million) 2017-2028
Table 23 Human Nutrition Market, by Region (Usd Million) 2017-2028
Table 24 Cosmetics Market, by Region -Under Covid-19 (Usd Million) 2017-2028
Table 25 Cosmetics Market, by Region (Usd Million) 2017-2028
Table 26 Animal Feed Additives Market, by Region -Under Covid- - 19 (Usd Million) 2017-2028
Table 27 Animal Feed Additives Market, by Region (Usd Million) 2017-2028
Table 28 Others Market, by Region -Under Covid-19 (Usd Million) 2017-2028
Table 29 Others Market, by Region (Usd Million) 2017-2028
Table 30 Global Retinyl Palmitate Market, by Region- Under Covid-19 (Usd Million) 2017-2028
Table 31 Global Retinyl Palmitate Market, by Region (Usd Million) 2017-2028
Table 32 North America Retinyl Palmitate Market, by Country - Under Covid- -19 (Usd Million) 2017-2028
Table 33 North America Retinyl Palmitate Market, by Country (Usd Million) 2017-2028
Table 34 North America Retinyl Palmitate Market - by Type - Under Covid-19 (Usd Million) 2017-2028
Table 35 North America Retinyl Palmitate Market - by Type (Usd Million) 2017-2028
Table 36 North America Retinyl Palmitate Market - by Product Type- Under Covid-19 (Usd Million) 2017-2028
Table 37 North America Retinyl Palmitate Market - by Product Type (Usd Million) 2017-2028
Table 38 North America Retinyl Palmitate Market - by Application - Under Covid-19 (Usd Million) 2017-2028
Table 39 North America Retinyl Palmitate Market - by Application (Usd Million) 2017-2028
Table 40 Asia-Pacific Retinyl Palmitate Market, by Country -Under Covid-19 (Usd Million) 2017-2028
Table 41 Asia-Pacific Retinyl Palmitate Market, by Country (Usd Million) 2017-2028
Table 42 Asia-Pacific Retinyl Palmitate Market - by Type - Under Covid-19 (Usd Million) 2017-2028
Table 43 Asia-Pacific Retinyl Palmitate Market - by Type (Usd Million) 2017-2028
Table 44 Asia-Pacific Retinyl Palmitate Market - by Product - Under Covid-19 (Usd Million) 2017-2028
Table 45 Asia-Pacific Retinyl Palmitate Market - by Product Type (Usd Million) 2017-2028
Table 46 Asia-Pacific Retinyl Palmitate Market - by Application - Under Covid-19 (Usd Million) 2017-2028
Table 47 Asia-Pacific Retinyl Palmitate Market - by Application (Usd Million) 2017-2028
Table 48 Europe Retinyl Palmitate Market, by Country - Under Covid-19 (Usd Million) 2017-2028
Table 49 Europe Retinyl Palmitate Market, by Country (Usd Million) 2017-2028
Table 50 Europe Retinyl Palmitate Market - by Type - Under Covid-19 (Usd Million) 2017-2028
Table 51 Europe Retinyl Palmitate Market - by Type (Usd Million) 2017-2028
Table 52 Europe Retinyl Palmitate Market - by Product Type - Under Covid-19 (Usd Million) 2017-2028
Table 53 Europe Retinyl Palmitate Market - by Product Type (Usd Million) 2017-2028
Table 54 Europe Retinyl Palmitate Market - by Application - Under Covid-19 (Usd Million) 2017-2028
Table 55 Europe Retinyl Palmitate Market - by Applicatoi (Usd Million) 2017-2028
Table 56 Middle East & Africa Retinyl Palmitate Market, by Country-Under Covid-19 (Usd Million) 2017-2028
Table 57 Middle East & Africa Retinyl Palmitate Market, by Country (Usd Million) 2017-2028
Table 58 Middle East & Africa Retinyl Palmitate Market - by Type - Under Covid-19 (Usd Million) 2017-2028
Table 59 Middle East & Africa Retinyl Palmitate Market - by Type (Usd Million) 2017-2028
Table 60 Middle East & Africa Retinyl Palmitate Market - by Product Type- Under Covid-19 (Usd Million) 2017-2028
Table 61 Middle East & Africa Retinyl Palmitate Market - by Product Type (Usd Million) 2017-2028
Table 62 Middle East & Africa Retinyl Palmitate Market - by Application - Under Covid-19 (Usd Million) 2017-2028
Table 63 Middle East & Africa Retinyl Palmitate Market - by Application (Usd Million) 2017-2028
Table 64 South America Retinyl Palmitate Market, by Country -Under Covid-19 (Usd Million) 2017-2028
Table 65 South America Retinyl Palmitate Market, by Country (Usd Million) 2017-2028
Table 66 South America Retinyl Palmitate Market - by Type - Under Covid-19 (Usd Million) 2017-2028
Table 67 South America Retinyl Palmitate Market - by Type (Usd Million) 2017-2028
Table 68 South America Retinyl Palmitate Market - by Product Type- Under Covid-19 (Usd Million) 2017-2028
Table 69 South America Retinyl Palmitate Market - by Product Type (Usd Million) 2017-2028
Table 70 South America Retinyl Palmitate Market - by Application - Under Covid-19 (Usd Million) 2017-2028
Table 71 South America Retinyl Palmitate Market - by Application (Usd Million) 2017-2028
List of Figures
Figure 1 Global Retinyl Palmitate Market: by Type, 2020 & 2028
Figure 2 Global Retinyl Palmitate Market: by Product Type, 2020 & 2028
Figure 3 Global Retinyl Palmitate Market: by Application, 2020 & 2028
Figure 4 Global Retinyl Palmitate Market: by Region, 2017-2028
Figure 5 Global Retinyl Palmitate Market - Market Scope
Figure 6 Global Retinyl Palmitate Market -Research Practice
Figure 7 Global Retinyl Palmitate Market -Research Methodology
Figure 8 Global Retinyl Palmitate Market -Primary and Secondary Research
Figure 9 Product Positioning Type, Product Type, and Application
Figure 10 Regional Reach Positioning
Figure 11 Droc Analysis
Figure 12 Porter's Five Forces Model- Global Retinyl Palmitate Market
Figure 13 Global Retinyl Palmitate Market, by Type 2017-2028
Figure 14 Global Retinyl Palmitate Market, by Product Type
Figure 15 Global Retinyl Palmitate Market, by Application
Figure 16 Global Retinyl Palmitate Market - by Region
Figure 17 North America Retinyl Palmitate Market Snapshot
Figure 18 North America Retinyl Palmitate Market - by Country 2017-2028
Figure 19 North America Retinyl Palmitate Market - by Type 2017-2028
Figure 20 North America Retinyl Palmitate Market - by Product 2017-2028
Figure 21 North America Retinyl Palmitate Market - by Application, 2017-2028
Figure 22 Asia-Pacific Retinyl Palmitate Market Snapshot
Figure 23 Asia-Pacific Retinyl Palmitate Market - by Country ,2017-2028
Figure 24 Asia-Pacific Retinyl Palmitate Market - by Type 2017-2028
Figure 25 Asia-Pacific Retinyl Palmitate Market - by Product 2017-2028
Figure 26 Asia-Pacific Retinyl Palmitate Market - by Application, 2017-2028
Figure 27 Europe Retinyl Palmitate Market Snapshot
Figure 28 Europe Retinyl Palmitate Market - by Country 2017-2028
Figure 29 Europe Retinyl Palmitate Market - by Type 2017-2028
Figure 30 Europe Retinyl Palmitate Market - by Product 2017-2028
Figure 31 Europe Retinyl Palmitate Market - by Application 2017-2028
Figure 32 Middle East & Africa Retinyl Palmitate Market Snapshot
Figure 33 Middle East & Africa Retinyl Palmitate Market - by Country, 2017-2028
Figure 34 Middle East & Africa Retinyl Palmitate Market - by Type 2017-2028
Figure 35 Middle East & Africa Retinyl Palmitate Market - by Product 2017-2028
Figure 36 Middle East & Africa Retinyl Palmitate Market - by Application 2017-2028
Figure 37 South America Retinyl Palmitate Market Snapshot
Figure 38 South America Retinyl Palmitate Market - by Country ,2017-2028
Figure 39 South America Retinyl Palmitate Market - by Type 2017-2028
Figure 40 South America Retinyl Palmitate Market - by Product Type 2017-2028
Figure 41 South America Retinyl Palmitate Market - by Application, 2017-2028
Figure 42 Royal Dsm (Business Overview)
Figure 43 Royal Dsm (Financial Overview)
Figure 44 Royal Dsm: SWOT Analysis
Figure 45 Archer Daniels Midland (Adm) (Business Overview)
Figure 46 Archer Daniels Midland (Adm) (Financial Overview)
Figure 47 Archer Daniels Midland (Adm): SWOT Analysis
Figure 48 Piramal Pharma Solutions (Business Overview)
Figure 49 Piramal Pharma Solutions (Financial Overview)
Figure 50 Piramal Pharma Solutions: SWOT Analysis
Figure 51 Basf Se (Business Overview)
Figure 52 Basf Se (Financial Overview)
Figure 53 Basf Se: SWOT Analysis
Figure 54 Divi's Laboratories Limited (Business Overview)
Figure 55 Divi's Laboratories Limited (Financial Overview)
Figure 56 Divi's Laboratories Limited: SWOT Analysis
Figure 57 Bluestar Adisseo: (Business Overview)
Figure 58 Bluestar Adisseo (Parent Company Financial Overview)
Figure 59 Bluestar Adisseo: SWOT Analysis
Figure 60 Pfizer Inc. (Business Overview)
Figure 61 Pfizer Inc. (Financial Overview)
Figure 62 Bayer Ag: (Business Overview)
Figure 63 Bayer AG (Parent Company Financial Overview)
Figure 64 Bayer Ag: SWOT Analysis
Figure 65 Rochem International Inc. (Business Overview)
Figure 66 Hangzhou Think Chemical Co. Ltd (Thinkchem) (Business Overview)
Figure 67 Xiamen Kingdomway Group Company (Business Overview)
Figure 68 Kangcare Bioindustry Co, Ltd (Business Overview)
Figure 69 Pharmavite (Business Overview)
Figure 70 Crystal Pharma (Business Overview)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Royal Dsm
  • Archer Daniels Midland (Adm)
  • Piramal Pharma Solutions
  • Basf Se
  • Divi’S Laboratories Limited
  • Bluestar Adisseo
  • Pfizer Inc. Bayer Ag
  • Rochem International Inc.
  • Hangzhou Think Chemical Co. Ltd (Thinkchem)
  • Xiamen Kingdomway Group Company
  • Kangcare Bioindustry Co Ltd
  • Pharmavite
  • Crystal Pharma